Drug-Drug Interaction Between R1_PBK_M2301 and R2_PBK_M2301 in Healthy Adults

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

June 1, 2025

Primary Completion Date

July 30, 2025

Study Completion Date

August 30, 2025

Conditions
Drug-Drug Interaction Healthy Volunteers
Interventions
DRUG

R1_PBK_M2301(Levocloperastine 60mg)

R1\_PBK\_M2301 is a test drug containing 60mg of levocloperastine per tablet. It is administered orally to evaluate pharmacokinetic characteristics and potential drug-drug interactions with R2\_PBK\_M2301 in healthy adult volunteers.

DRUG

R2_PBK_M2301 (Pelargonium sidoides extract)

R2\_PBK\_M2301 is an oral tablet containing 20 mg of Pelargonium sidoides 11% ethanol extract, used as a comparator to evaluate potential pharmacokinetic interactions with R1\_PBK\_M2301.

Trial Locations (1)

08799

H+ Yangji Hospital, Seoul

Sponsors
All Listed Sponsors
lead

Pharmbio Korea Co., Ltd.

INDUSTRY